Study of Dupilumab in Adult Participants With Active Eosinophilic Esophagitis (EoE)
Clinical trial NCT02379052 · COMPLETED
Trial details
- NCT number
- NCT02379052
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-12
- Primary completion
- 2017-02-17
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.